Standout Papers
Citation Impact
Citing Papers
Pharmaceutical Particle Engineering via Spray Drying
2007 Standout
No health without mental health
2007 Standout
Women, sex, and HIV: Social and contextual factors, meta-analysis of published interventions, and implications for practice and research.
2002
The nature of procrastination: A meta-analytic and theoretical review of quintessential self-regulatory failure.
2007 Standout
Influence of social perception and social knowledge on cognitive and social functioning in early psychosis
2006
Recombinant Protein-Stabilized Monodisperse Microbubbles with Tunable Size Using a Valve-Based Microfluidic Device
2014
Sexual behaviour in context: a global perspective
2006 Standout
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
Does low self-esteem predict depression and anxiety? A meta-analysis of longitudinal studies.
2012 Standout
Predictors of posttraumatic stress disorder and symptoms in adults: A meta-analysis.
2003 Standout
Chlorpromazine versus placebo for schizophrenia
2007
Motivation and its Relationship to Neurocognition, Social Cognition, and Functional Outcome in Schizophrenia
2009
Neurocognition, Social Cognition, Perceived Social Discomfort, and Vocational Outcomes in Schizophrenia
2008
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
1998 Standout
Neural Synchrony in Brain Disorders: Relevance for Cognitive Dysfunctions and Pathophysiology
2006 Standout
Serious mental disorder in 23 000 prisoners: a systematic review of 62 surveys
2002 Standout
Schizophrenia
2009 Standout
Psychiatric genetics: search for phenotypes
1998
Influence of context effects on health outcomes: a systematic review
2001 Standout
Effects of Six Months of Clozapine Treatment on the Quality of Life of Chronic Schizophrenic Patients
1990
Effects of Antipsychotic Medications on Psychosocial Functioning in Patients With Chronic Schizophrenia: Findings From the NIMH CATIE Study
2007
Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia
2006
Effects of Olanzapine, Quetiapine, and Risperidone on Neurocognitive Function in Early Psychosis: A Randomized, Double-Blind 52-Week Comparison
2007
Duration of untreated psychosis: a critical examination of the concept and its importance
2001
Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS
2004
Neuropeptides, Dopamine, and Schizophreniaa
1988
Adherence to Antipsychotic and Nonpsychiatric Medications in Middle-Aged and Older Patients With Psychotic Disorders
2003
The adolescent brain and age-related behavioral manifestations
2000 Standout
A principal-components analysis of the Narcissistic Personality Inventory and further evidence of its construct validity.
1988 Standout
The Functional Significance of Social Cognition in Schizophrenia: A Review
2006
Social and cognitive functioning in psychosis
2007
Facial affect recognition: A mediator between cognitive and social functioning in psychosis?
2006
REHAB: A New Assessment Instrument for Chronic Psychiatric Patients
1988
Effectiveness and Cost of Olanzapine and Haloperidol in the Treatment of Schizophrenia<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2003
Development of a rational scale to assess the harm of drugs of potential misuse
2007 Standout
UCSD Performance-Based Skills Assessment: Development of a New Measure of Everyday Functioning for Severely Mentally Ill Adults
2001
Self-compassion and reactions to unpleasant self-relevant events: The implications of treating oneself kindly.
2007 Standout
Community dysfunction in schizophrenia: Rate-limiting factors
2006
The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: A meta-analysis
2010 Standout
Sex differences in trauma and posttraumatic stress disorder: A quantitative review of 25 years of research.
2006 Standout
Prevalence of and Risk Factors for Medication Nonadherence in Patients With Schizophrenia
2002 Standout
Risk factors for suicidal thoughts and behaviors: A meta-analysis of 50 years of research.
2016 Standout
Maxims or myths of beauty? A meta-analytic and theoretical review.
2000 Standout
Independent frontal-system deficits in schizophrenia: cognitive, clinical, and adaptive implications
1999
Intrinsic motivation, neurocognition and psychosocial functioning in schizophrenia: Testing mediator and moderator effects
2008
Dose Response and Dose Equivalence of Antipsychotics
2004
Rethinking schizophrenia
2010 StandoutNature
The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance
1994
Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study
2000
Perphenazine for schizophrenia
2005
Changing Environments and Alternative Perspectives in Evaluating the Cost-Effectiveness of New Antipsychotic Drugs
2003
Monitoring and Care of Young People at Incipient Risk of Psychosis
1996
Diazepam Treatment of Early Signs of Exacerbation in Schizophrenia
1999
The functional relevance of affect recognition errors in schizophrenia
2000
Drug Policy: Striking the Right Balance
1990 Science
Impact of sexual abuse on children: A review and synthesis of recent empirical studies.
1993 Standout
Mental health of young people: a global public-health challenge
2007 Standout
Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons
1995 StandoutNobel
The structure of negative emotional states: Comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories
1995 Standout
Epidemiology and natural history of schizophrenia
1999
Validating Measures of Real-World Outcome: The Results of the VALERO Expert Survey and RAND Panel
2009
Effective Medical Treatment of Opiate Addiction
1998
Suicidal behaviour in early psychosis
2004
Perfectionism in the self and social contexts: Conceptualization, assessment, and association with psychopathology.
1991 Standout
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
2003 Standout
How does sexual minority stigma “get under the skin”? A psychological mediation framework.
2009 Standout
Is phase‐specific, community‐oriented treatment of early psychosis‐ an economically viable method of improving outcome?
1999
The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project: Schizophrenia Trial Design and Protocol Development
2003
The missing ‘P’ in pain management: how the current opioid epidemic highlights the need for psychiatric services in chronic pain care
2013
Drug Dependence, a Chronic Medical Illness
2000 Standout
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Social function in schizophrenia and schizoaffective disorder: associations with personality, symptoms and neurocognition.
2004
Should we ask our children about sex, drugs and rock & roll? Potentially harmful effects of asking questions about risky behaviors
2008
Assessing Clinical and Functional Outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial
2003
Glass capillary microfluidics for production of monodispersed poly (dl-lactic acid) and polycaprolactone microparticles: Experiments and numerical simulations
2013
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
Adherence to Medication
2005 Standout
Microfluidic synthesis of monodisperse porous microspheres with size-tunable pores
2012
Psychoeducation for schizophrenia
2011
Chlorpromazine versus placebo for schizophrenia
2014
The EPPIC Follow-Up Study of First-Episode Psychosis
2010
Treatment of Negative Symptoms
1985
Quality of life bibliography and indexes.
1990
An inventory for measuring clinical anxiety: Psychometric properties.
1988 Standout
Self-inhibition by Dopaminergic Neurons
1975 Science
Factors Affecting Self-Esteem, Depression, and Negative Behaviors in Sexually Abused Female Adolescents
1989
Situational factors contributing to the placebo effect
1978
Posttraumatic stress disorder among substance users from the general population
1992
Temporal relationship between change in cognition and change in functioning in schizophrenia
2008
The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia
1987 Standout
Assessment of Negative and Positive Symptoms in Schizophrenia
1983
Cortical inhibitory neurons and schizophrenia
2005 Standout
Initial Anticholinergic Prophylaxis for Neuroleptic-Induced Extrapyramidal Syndromes
1983
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Relationships Between Cognitive Deficits, Symptoms and Quality of Life in Schizophrenia
2008
A New Depression Scale Designed to be Sensitive to Change
1979 Standout
Screening Depressed Patients in Family Practice
1972 Standout
An overview of family interventions and relapse on schizophrenia: meta-analysis of research findings
1994
A Critical Appraisal of the Quality of Quality-of-Life Measurements
1994 Standout
What are the functional consequences of neurocognitive deficits in schizophrenia?
1996 Standout
Perphenazine for schizophrenia
2015
ADOLESCENT RESILIENCE: A Framework for Understanding Healthy Development in the Face of Risk
2004 Standout
Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation
1988 Standout
Positive and negative syndromes in schizophrenia as a function of chronicity
1986
The Efficacy of Antidepressant Drugs
1974
Endogenous opioid ligands may mediate stress-induced changes in the affective properties of pain related behavior in rats
1978
Antipsychotic Drugs, Neurotransmitters, and Schizophrenia
1978 StandoutNobel
Differences in Criminal Activity Between Heroin Abusers and Subjects Without Psychiatric Disorders—Analysis of 578 Detainees in Bilbao, Spain
1998
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
2000 Standout
A quality of life interview for the chronically mentally ill
1988 Standout
Antiparkinsonian Agents and Depot Phenothiazine
1974
Effect of Hypericum perforatum (St John's Wort) in Major Depressive Disorder
2002 Standout
Emerging Droplet Microfluidics
2017 Standout
Cross‐validation of self‐report measures of depression among normal populations of Japanese, Chinese, and Caucasian ancestry
1975
The relationship between anxiety and depression
1985
Opioid and Nonopioid Mechanisms of Stress Analgesia
1980 StandoutScience
Psychic and Somatic Symptoms of Depression Among Young Adults, Institutionalized Aged and Noninstitutionalized Aged
1979
Being surveyed can change later behavior and related parameter estimates
2011 StandoutNobel
Works of Thomas E. Hanlon being referenced
Perceptions of Social Pathology in the Neighborhood and the Etiology of Narcotic Addiction A Retrospective Study
1996
Clinical predictors of relapse following neuroleptic withdrawal
1992
The consistency of types of criminal behavior over preaddiction, addiction, and nonaddiction status periods
1989
Early family adversity as a precursor to narcotic addiction
1996
Porous PLGA microparticles: AI-700, an intravenously administered ultrasound contrast agent for use in echocardiography
2005
A Classification of Narcotic Addicts Based on Type, Amount and Severity of Crime
1991
A PSYCHOPHARMACOLOGICAL STUDY OF CATECHOLAMINES IN AFFECTIVE DISORDERS
1974
PRE-ADMISSION DRUG TREATMENT OF STATE PSYCHIATRIC HOSPITAL PATIENTS
1959
THE PSYCHIATRIC PHYSICIAN AND THE PHENOTHIAZINE TRANQUILIZERS
1960
The Criminality of Narcotic Addicts
1985
A COMPARATIVE STUDY OF CHLORPROMAZINE AND TRIFLUPROMAZINE IN THE MANAGEMENT OF THE CHRONIC HOSPITALIZED PSYCHOTIC PATIENT
1958
Dr. Carpenter and Associates Reply
1988
Trends in Criminal Activity and Drug Use over an Addiction Career
1990
Congruence of self and ideal self in relation to personality adjustment.
1954
Intravenous nialamide in the treatment of depressed female patients
1963
COMPARATIVE STUDIES OF THE PHENOTHIAZINE TRANQUILIZERS
1961
The comparative effectiveness of eight phenothiazines
1965
Perphenazine-benztropine mesylate treatment of newly admitted psychiatric patients
1966
A comparative trial of pharmacologic strategies in schizophrenia
1987
An Early Community-Based Intervention for the Prevention of Substance Abuse and Other Delinquent Behavior
2002
The Quality of Life Scale: An Instrument for Rating the Schizophrenic Deficit Syndrome
1984 Standout
Continuous versus targeted medication in schizophrenic outpatients: outcome results [published erratum appears in Am J Psychiatry 1991 Jun;148(6):819]
1990
The treatment of perceptual disturbances in schizophrenia with naloxone hydrochloride
1977
Methodologic standards for treatment outcome research in schizophrenia
1981
The Comparative Effectiveness of Amitriptyline, Perphenazine, and Their Combination in the Treatment of Chronic Psychotic Female Patients
1964